Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Vein Occlusion with Macular Oedema”

Showing 16 of 0 results

Large-scale testing (Phase 3)Study completedNCT04740905
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Hoffmann-La Roche 553
Large-scale testing (Phase 3)Study completedNCT01535261
What this trial is testing

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Novartis Pharmaceuticals 357
Testing effectiveness (Phase 2)Study completedNCT01724554
What this trial is testing

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion

Who this might be right for
Central Retinal Vein OcclusionProliferative Diabetic Retinopathy
Ophthalmic Consultants of Boston 24
Testing effectiveness (Phase 2)Study completedNCT01662518
What this trial is testing

DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Centro de Pesquisa Rubens Siqueira 10
Post-approval studies (Phase 4)Looking for participantsNCT07133438
What this trial is testing

Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment

Who this might be right for
Retinal Vein Occlusion (RVO)
First Affiliated Hospital of Chongqing Medical University 120
Post-approval studies (Phase 4)Study completedNCT06234514
What this trial is testing

Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab

Who this might be right for
Macular Cystoid Edema
Dongyang People's Hospital 111
Testing effectiveness (Phase 2)Study completedNCT03927690
What this trial is testing

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 91
Large-scale testing (Phase 3)Study completedNCT00942864
What this trial is testing

Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Novartis Korea Ltd. 40
Post-approval studies (Phase 4)UnknownNCT03892434
What this trial is testing

Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 40
Large-scale testing (Phase 3)Ended earlyNCT03802630
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 450
Testing effectiveness (Phase 2)Study completedNCT04576689
What this trial is testing

Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy

Who this might be right for
Diabetic Macular OedemaRetinal Vein Occlusion with Macular Oedema
Ripple Therapeutics Pty Ltd 60
Testing effectiveness (Phase 2)Study completedNCT00088283
What this trial is testing

Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Eyetech Pharmaceuticals 90
Testing effectiveness (Phase 2)Study completedNCT04667897
What this trial is testing

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT05850520
What this trial is testing

Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Who this might be right for
Macular Edema Secondary to Retinal Vein Occlusion
Bayer 892
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT02118831
What this trial is testing

Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF

Who this might be right for
Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
California Retina Consultants 56

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation